Latest Commercialisation News

Page 161 of 171
Cleo Diagnostics reports steady progress in its U.S. and Australian clinical trials for an ovarian cancer blood test, maintaining a solid cash reserve of A$7.3 million as it prepares for FDA submission.
Ada Torres
Ada Torres
31 Jan 2025
Alexium International Group reports a 16% sales increase in Q2 FY25 despite ongoing mattress market softness, driven by strategic product diversification and supply chain improvements.
Victor Sage
Victor Sage
31 Jan 2025
Accelerate Resources has secured a 70% stake in the Kanowna East Gold Project near Kalgoorlie and raised $1.35 million to accelerate exploration, while also identifying lithium-bearing spodumene at Mt Sholl East.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Echo IQ confirms the material significance of its pre-submission FDA meeting for EchoSolv HF, marking a pivotal step toward US market entry and commercialisation.
Ada Torres
Ada Torres
31 Jan 2025
Pure Resources Limited has made significant strides in its Reedy Creek Garnet Project, expanding the resource and delivering promising metallurgical test results that highlight the project's commercial potential.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Cambium Bio has secured a A$3 million capital raise and achieved FDA Fast Track status for its lead ophthalmology product, Elate Ocular®, setting the stage for Phase 3 trials in mid-2025.
Ada Torres
Ada Torres
31 Jan 2025
Cokal Limited has strengthened its position in Central Kalimantan through strategic partnerships with PT Petrindo and Cratus Group, securing US$20 million in funding to boost coal production and infrastructure development.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Tissue Repair Limited reports initial patient enrolment in its pivotal Phase 3 trial for TR987®, alongside a robust 35% quarterly sales increase for its TR Pro+® product. The company is also advancing manufacturing and distribution strategies to support growth.
Ada Torres
Ada Torres
31 Jan 2025
Wide Open Agriculture reports a 50% reduction in overheads alongside the development of a novel lupin-based tofu product, positioning itself for growth in the global plant protein market.
Ada Torres
Ada Torres
31 Jan 2025
Papyrus Australia has taken significant strides in Q4 2024, signing a joint venture terms sheet in Vietnam, appointing new board members, and securing R&D tax incentives, positioning itself for expanded commercialization.
Victor Sage
Victor Sage
31 Jan 2025
ReNu Energy reports progress on a management buyout proposal for its hydrogen subsidiary and completes sale of legacy geothermal assets, signaling a strategic pivot and ongoing capital challenges.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Audio Pixels Holdings Limited reports significant technical progress in its Digital Sound Reconstruction technology and secures additional funding through convertible notes, while continuing to navigate ASX suspension challenges.
Sophie Babbage
Sophie Babbage
31 Jan 2025